Mistral CEO Arthur Mensch thinks the clamor from people like Elon Musk to declare AI as smarter than humans is driven by an ...

Google's DeepMind leads the market with Gemini, TPU chips, and cloud growth, making its valuations compelling compared to its ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

But China isn’t standing still. The country is already looking beyond DeepSeek, with plans to integrate AI into emerging ...